UniProt ID | NUP62_HUMAN | |
---|---|---|
UniProt AC | P37198 | |
Protein Name | Nuclear pore glycoprotein p62 | |
Gene Name | NUP62 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 522 | |
Subcellular Localization | Nucleus, nuclear pore complex . Cytoplasm, cytoskeleton, spindle pole . Nucleus envelope . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Central region of the nuclear pore, within the transporter (PubMed:1915414). During mitoti | |
Protein Description | Essential component of the nuclear pore complex. [PubMed: 1915414 The N-terminal is probably involved in nucleocytoplasmic transport] | |
Protein Sequence | MSGFNFGGTGAPTGGFTFGTAKTATTTPATGFSFSTSGTGGFNFGAPFQPATSTPSTGLFSLATQTPATQTTGFTFGTATLASGGTGFSLGIGASKLNLSNTAATPAMANPSGFGLGSSNLTNAISSTVTSSQGTAPTGFVFGPSTTSVAPATTSGGFSFTGGSTAQPSGFNIGSAGNSAQPTAPATLPFTPATPAATTAGATQPAAPTPTATITSTGPSLFASIATAPTSSATTGLSLCTPVTTAGAPTAGTQGFSLKAPGAASGTSTTTSTAATATATTTSSSSTTGFALNLKPLAPAGIPSNTAAAVTAPPGPGAAAGAAASSAMTYAQLESLINKWSLELEDQERHFLQQATQVNAWDRTLIENGEKITSLHREVEKVKLDQKRLDQELDFILSQQKELEDLLSPLEELVKEQSGTIYLQHADEEREKTYKLAENIDAQLKRMAQDLKDIIEHLNTSGAPADTSDPLQQICKILNAHMDSLQWIDQNSALLQRKVEEVTKVCEGRRKEQERSFRITFD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSGFNFGGT ------CCCCCCCCC | 52.68 | 22223895 | |
2 | Phosphorylation | ------MSGFNFGGT ------CCCCCCCCC | 52.68 | 26074081 | |
9 | Phosphorylation | SGFNFGGTGAPTGGF CCCCCCCCCCCCCCE | 30.46 | 26074081 | |
13 | O-linked_Glycosylation | FGGTGAPTGGFTFGT CCCCCCCCCCEEEEC | 49.78 | 31492838 | |
17 | O-linked_Glycosylation | GAPTGGFTFGTAKTA CCCCCCEEEECCEEC | 25.16 | 31492838 | |
20 | O-linked_Glycosylation | TGGFTFGTAKTATTT CCCEEEECCEECCCC | 22.31 | 31492838 | |
20 | Phosphorylation | TGGFTFGTAKTATTT CCCEEEECCEECCCC | 22.31 | - | |
23 | O-linked_Glycosylation | FTFGTAKTATTTPAT EEEECCEECCCCCCC | 27.11 | 31492838 | |
25 | O-linked_Glycosylation | FGTAKTATTTPATGF EECCEECCCCCCCCE | 36.11 | 31492838 | |
26 | O-linked_Glycosylation | GTAKTATTTPATGFS ECCEECCCCCCCCEE | 28.46 | 31492838 | |
27 | O-linked_Glycosylation | TAKTATTTPATGFSF CCEECCCCCCCCEEE | 13.43 | 31492838 | |
30 | O-linked_Glycosylation | TATTTPATGFSFSTS ECCCCCCCCEEEECC | 39.71 | 31492838 | |
33 | O-linked_Glycosylation | TTPATGFSFSTSGTG CCCCCCEEEECCCCC | 21.45 | 31492838 | |
35 | O-linked_Glycosylation | PATGFSFSTSGTGGF CCCCEEEECCCCCCC | 22.06 | 31492838 | |
36 | O-linked_Glycosylation | ATGFSFSTSGTGGFN CCCEEEECCCCCCCC | 29.21 | 31492838 | |
37 | O-linked_Glycosylation | TGFSFSTSGTGGFNF CCEEEECCCCCCCCC | 32.91 | 31492838 | |
39 | O-linked_Glycosylation | FSFSTSGTGGFNFGA EEEECCCCCCCCCCC | 33.62 | 31492838 | |
52 | O-linked_Glycosylation | GAPFQPATSTPSTGL CCCCCCCCCCCCCCC | 39.55 | 31492838 | |
53 | O-linked_Glycosylation | APFQPATSTPSTGLF CCCCCCCCCCCCCCE | 40.19 | 31492838 | |
54 | O-linked_Glycosylation | PFQPATSTPSTGLFS CCCCCCCCCCCCCEE | 19.53 | 31492838 | |
56 | O-linked_Glycosylation | QPATSTPSTGLFSLA CCCCCCCCCCCEEEC | 34.88 | 31492838 | |
57 | O-linked_Glycosylation | PATSTPSTGLFSLAT CCCCCCCCCCEEECC | 38.82 | 31492838 | |
61 | O-linked_Glycosylation | TPSTGLFSLATQTPA CCCCCCEEECCCCCC | 23.33 | 31492838 | |
64 | O-linked_Glycosylation | TGLFSLATQTPATQT CCCEEECCCCCCCCC | 37.96 | 31492838 | |
66 | O-linked_Glycosylation | LFSLATQTPATQTTG CEEECCCCCCCCCCC | 15.55 | 31492838 | |
69 | O-linked_Glycosylation | LATQTPATQTTGFTF ECCCCCCCCCCCEEE | 27.87 | 31492838 | |
71 | O-linked_Glycosylation | TQTPATQTTGFTFGT CCCCCCCCCCEEEEE | 25.24 | 31492838 | |
72 | O-linked_Glycosylation | QTPATQTTGFTFGTA CCCCCCCCCEEEEEE | 22.08 | 31492838 | |
75 | O-linked_Glycosylation | ATQTTGFTFGTATLA CCCCCCEEEEEEEEC | 23.62 | 31492838 | |
78 | O-linked_Glycosylation | TTGFTFGTATLASGG CCCEEEEEEEECCCC | 16.57 | 31492838 | |
89 | O-linked_Glycosylation | ASGGTGFSLGIGASK CCCCCCCEEEECCCC | 27.34 | 31492838 | |
95 | O-linked_Glycosylation | FSLGIGASKLNLSNT CEEEECCCCCCCCCC | 32.25 | 31492838 | |
100 | O-linked_Glycosylation | GASKLNLSNTAATPA CCCCCCCCCCCCCCC | 30.94 | 31492838 | |
102 | O-linked_Glycosylation | SKLNLSNTAATPAMA CCCCCCCCCCCCCCC | 17.81 | 31492838 | |
105 | O-linked_Glycosylation | NLSNTAATPAMANPS CCCCCCCCCCCCCCC | 14.76 | 31492838 | |
112 | O-linked_Glycosylation | TPAMANPSGFGLGSS CCCCCCCCCCCCCCC | 46.70 | 31492838 | |
118 | O-linked_Glycosylation | PSGFGLGSSNLTNAI CCCCCCCCCCHHHHH | 22.54 | 31492838 | |
119 | O-linked_Glycosylation | SGFGLGSSNLTNAIS CCCCCCCCCHHHHHH | 33.78 | 31492838 | |
122 | O-linked_Glycosylation | GLGSSNLTNAISSTV CCCCCCHHHHHHCEE | 27.18 | 31492838 | |
126 | O-linked_Glycosylation | SNLTNAISSTVTSSQ CCHHHHHHCEECCCC | 19.97 | 31492838 | |
127 | O-linked_Glycosylation | NLTNAISSTVTSSQG CHHHHHHCEECCCCC | 22.30 | 31492838 | |
128 | O-linked_Glycosylation | LTNAISSTVTSSQGT HHHHHHCEECCCCCC | 22.47 | 31492838 | |
130 | O-linked_Glycosylation | NAISSTVTSSQGTAP HHHHCEECCCCCCCC | 23.81 | 31492838 | |
131 | O-linked_Glycosylation | AISSTVTSSQGTAPT HHHCEECCCCCCCCC | 19.14 | 31492838 | |
132 | O-linked_Glycosylation | ISSTVTSSQGTAPTG HHCEECCCCCCCCCE | 24.22 | 31492838 | |
135 | O-linked_Glycosylation | TVTSSQGTAPTGFVF EECCCCCCCCCEEEE | 23.10 | 31492838 | |
138 | O-linked_Glycosylation | SSQGTAPTGFVFGPS CCCCCCCCEEEECCC | 40.56 | 31492838 | |
145 | O-linked_Glycosylation | TGFVFGPSTTSVAPA CEEEECCCCCCCCCC | 44.70 | 31492838 | |
146 | O-linked_Glycosylation | GFVFGPSTTSVAPAT EEEECCCCCCCCCCC | 26.65 | 31492838 | |
147 | O-linked_Glycosylation | FVFGPSTTSVAPATT EEECCCCCCCCCCCC | 26.07 | 31492838 | |
148 | O-linked_Glycosylation | VFGPSTTSVAPATTS EECCCCCCCCCCCCC | 19.17 | 31492838 | |
153 | O-linked_Glycosylation | TTSVAPATTSGGFSF CCCCCCCCCCCCCEE | 22.04 | 31492838 | |
154 | O-linked_Glycosylation | TSVAPATTSGGFSFT CCCCCCCCCCCCEEC | 27.72 | 31492838 | |
155 | O-linked_Glycosylation | SVAPATTSGGFSFTG CCCCCCCCCCCEECC | 32.34 | 31492838 | |
159 | O-linked_Glycosylation | ATTSGGFSFTGGSTA CCCCCCCEECCCCCC | 25.77 | 31492838 | |
161 | O-linked_Glycosylation | TSGGFSFTGGSTAQP CCCCCEECCCCCCCC | 39.16 | 31492838 | |
169 | O-linked_Glycosylation | GGSTAQPSGFNIGSA CCCCCCCCCCCCCCC | 43.89 | 31492838 | |
175 | O-linked_Glycosylation | PSGFNIGSAGNSAQP CCCCCCCCCCCCCCC | 29.25 | 31492838 | |
179 | O-linked_Glycosylation | NIGSAGNSAQPTAPA CCCCCCCCCCCCCCC | 27.62 | 31492838 | |
183 | O-linked_Glycosylation | AGNSAQPTAPATLPF CCCCCCCCCCCCCCC | 32.94 | 31492838 | |
187 | O-linked_Glycosylation | AQPTAPATLPFTPAT CCCCCCCCCCCCCCC | 33.63 | 31492838 | |
191 | O-linked_Glycosylation | APATLPFTPATPAAT CCCCCCCCCCCCCCC | 15.29 | 31492838 | |
194 | O-linked_Glycosylation | TLPFTPATPAATTAG CCCCCCCCCCCCCCC | 18.05 | 31492838 | |
198 | O-linked_Glycosylation | TPATPAATTAGATQP CCCCCCCCCCCCCCC | 21.20 | 31492838 | |
199 | O-linked_Glycosylation | PATPAATTAGATQPA CCCCCCCCCCCCCCC | 20.54 | 31492838 | |
203 | O-linked_Glycosylation | AATTAGATQPAAPTP CCCCCCCCCCCCCCC | 33.88 | 31492838 | |
209 | O-linked_Glycosylation | ATQPAAPTPTATITS CCCCCCCCCCEEEEC | 28.66 | 31492838 | |
211 | O-linked_Glycosylation | QPAAPTPTATITSTG CCCCCCCCEEEECCC | 38.62 | 31492838 | |
215 | O-linked_Glycosylation | PTPTATITSTGPSLF CCCCEEEECCCHHHH | 18.84 | 31492838 | |
216 | O-linked_Glycosylation | TPTATITSTGPSLFA CCCEEEECCCHHHHH | 27.76 | 31492838 | |
224 | O-linked_Glycosylation | TGPSLFASIATAPTS CCHHHHHEEEECCCC | 12.86 | 31492838 | |
227 | O-linked_Glycosylation | SLFASIATAPTSSAT HHHHEEEECCCCCCC | 31.34 | 31492838 | |
230 | O-linked_Glycosylation | ASIATAPTSSATTGL HEEEECCCCCCCCCC | 32.61 | 31492838 | |
231 | O-linked_Glycosylation | SIATAPTSSATTGLS EEEECCCCCCCCCCC | 19.54 | 31492838 | |
232 | O-linked_Glycosylation | IATAPTSSATTGLSL EEECCCCCCCCCCCC | 31.92 | 31492838 | |
234 | O-linked_Glycosylation | TAPTSSATTGLSLCT ECCCCCCCCCCCCCC | 24.28 | 31492838 | |
235 | O-linked_Glycosylation | APTSSATTGLSLCTP CCCCCCCCCCCCCCC | 35.52 | 31492838 | |
238 | O-linked_Glycosylation | SSATTGLSLCTPVTT CCCCCCCCCCCCEEE | 23.81 | 31492838 | |
241 | O-linked_Glycosylation | TTGLSLCTPVTTAGA CCCCCCCCCEEECCC | 26.53 | 31492838 | |
244 | O-linked_Glycosylation | LSLCTPVTTAGAPTA CCCCCCEEECCCCCC | 16.48 | 31492838 | |
245 | O-linked_Glycosylation | SLCTPVTTAGAPTAG CCCCCEEECCCCCCC | 24.27 | 31492838 | |
250 | O-linked_Glycosylation | VTTAGAPTAGTQGFS EEECCCCCCCCCCEE | 36.87 | 31492838 | |
253 | O-linked_Glycosylation | AGAPTAGTQGFSLKA CCCCCCCCCCEEEEC | 24.05 | 31492838 | |
265 | O-linked_Glycosylation | LKAPGAASGTSTTTS EECCCCCCCCCCCCC | 41.91 | 31492838 | |
269 | O-linked_Glycosylation | GAASGTSTTTSTAAT CCCCCCCCCCCCEEE | 33.65 | 31492838 | |
269 | Phosphorylation | GAASGTSTTTSTAAT CCCCCCCCCCCCEEE | 33.65 | - | |
270 | O-linked_Glycosylation | AASGTSTTTSTAATA CCCCCCCCCCCEEEE | 20.65 | 31492838 | |
272 | O-linked_Glycosylation | SGTSTTTSTAATATA CCCCCCCCCEEEEEE | 17.60 | 31492838 | |
272 | Phosphorylation | SGTSTTTSTAATATA CCCCCCCCCEEEEEE | 17.60 | - | |
273 | Phosphorylation | GTSTTTSTAATATAT CCCCCCCCEEEEEEE | 20.44 | 28985074 | |
281 | Phosphorylation | AATATATTTSSSSTT EEEEEEEECCCCCCC | 23.40 | - | |
304 | O-linked_Glycosylation | LAPAGIPSNTAAAVT CCCCCCCCCCEEEEE | 44.91 | 31492838 | |
306 | O-linked_Glycosylation | PAGIPSNTAAAVTAP CCCCCCCCEEEEECC | 23.24 | 31492838 | |
306 | Phosphorylation | PAGIPSNTAAAVTAP CCCCCCCCEEEEECC | 23.24 | 22210691 | |
311 | O-linked_Glycosylation | SNTAAAVTAPPGPGA CCCEEEEECCCCCCH | 28.81 | 31492838 | |
325 | O-linked_Glycosylation | AAAGAAASSAMTYAQ HHHHHHHHHHCHHHH | 17.57 | 31492838 | |
329 | Phosphorylation | AAASSAMTYAQLESL HHHHHHCHHHHHHHH | 18.54 | 22210691 | |
335 | Phosphorylation | MTYAQLESLINKWSL CHHHHHHHHHHHHCC | 43.04 | 24719451 | |
371 | Acetylation | TLIENGEKITSLHRE HHHHCCHHHHHHHHH | 53.32 | 23236377 | |
371 | Ubiquitination | TLIENGEKITSLHRE HHHHCCHHHHHHHHH | 53.32 | 21890473 | |
373 | O-linked_Glycosylation | IENGEKITSLHREVE HHCCHHHHHHHHHHH | 35.98 | UniProtKB CARBOHYD | |
408 | Phosphorylation | KELEDLLSPLEELVK HHHHHHHHHHHHHHH | 34.43 | 28355574 | |
415 | Ubiquitination | SPLEELVKEQSGTIY HHHHHHHHHCCCCEE | 63.76 | - | |
418 | Phosphorylation | EELVKEQSGTIYLQH HHHHHHCCCCEEEEE | 38.71 | 30266825 | |
420 | Phosphorylation | LVKEQSGTIYLQHAD HHHHCCCCEEEEECH | 16.22 | 30266825 | |
422 | Phosphorylation | KEQSGTIYLQHADEE HHCCCCEEEEECHHH | 10.51 | 30266825 | |
434 | Phosphorylation | DEEREKTYKLAENID HHHHHHHHHHHHHHH | 18.31 | - | |
435 | Acetylation | EEREKTYKLAENIDA HHHHHHHHHHHHHHH | 46.59 | 25953088 | |
435 | Ubiquitination | EEREKTYKLAENIDA HHHHHHHHHHHHHHH | 46.59 | 21890473 | |
445 | 2-Hydroxyisobutyrylation | ENIDAQLKRMAQDLK HHHHHHHHHHHHHHH | 28.22 | - | |
445 | Ubiquitination | ENIDAQLKRMAQDLK HHHHHHHHHHHHHHH | 28.22 | 21890473 | |
452 | Ubiquitination | KRMAQDLKDIIEHLN HHHHHHHHHHHHHHH | 55.99 | - | |
467 | Phosphorylation | TSGAPADTSDPLQQI CCCCCCCCCCHHHHH | 36.82 | 23663014 | |
468 | O-linked_Glycosylation | SGAPADTSDPLQQIC CCCCCCCCCHHHHHH | 37.47 | UniProtKB CARBOHYD | |
468 | Phosphorylation | SGAPADTSDPLQQIC CCCCCCCCCHHHHHH | 37.47 | 23663014 | |
476 | Ubiquitination | DPLQQICKILNAHMD CHHHHHHHHHHHHHH | 52.43 | - | |
484 | Phosphorylation | ILNAHMDSLQWIDQN HHHHHHHHHHHHHHC | 18.19 | 29978859 | |
492 | Phosphorylation | LQWIDQNSALLQRKV HHHHHHCHHHHHHHH | 18.05 | 29978859 | |
498 | Ubiquitination | NSALLQRKVEEVTKV CHHHHHHHHHHHHHH | 40.83 | - | |
504 | Acetylation | RKVEEVTKVCEGRRK HHHHHHHHHHCCCCC | 50.49 | 25953088 | |
504 | Ubiquitination | RKVEEVTKVCEGRRK HHHHHHHHHHCCCCC | 50.49 | - | |
516 | Phosphorylation | RRKEQERSFRITFD- CCCCCCCCEEEECC- | 20.37 | 25159151 | |
520 | Phosphorylation | QERSFRITFD----- CCCCEEEECC----- | 19.93 | 22199227 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NUP62_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NUP62_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
271930 | Infantile striatonigral degeneration (SNDI) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...